Apeiron Investment Group Ltd., 10% Owner at ATAI Life Sciences N.V. (ATAI), bought 239,274 shares at $5.13 ($1.2M) on 2022-04-19, disclosed to the SEC on 2022-04-20.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.11 | 54,322 | $278K | 22.7% |
| 2 | $5.11 | 54,322 | $278K | 22.7% |
| 3 | $5.13 | 65,315 | $335K | 27.3% |
| 4 | $5.13 | 65,315 | $335K | 27.3% |
| Total | $5.12 avg | 239,274 | $1.2M | 100% |
| Filing → |
| ENHA | BUY | 2026-09-04 | $210K | — | Filing → |
| ENHA | BUY | 2026-08-20 | $2.9M | — | Filing → |
| ENHA | BUY | 2026-08-18 | $330K | — | Filing → |